Anergis Investors
Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.
Connections
Employee Number:
1-10
Founded Date:
2001
Industry:
Advanced Longevity (R&D)
Investor Type:
Healthcare Company
Headquarters:
Vaud